Growing in DMEM (glucose levels 25 mM-FBS; i.e., hyperglycemia) breast cancer MDA-MB-231P cells expressed the least VEGFR2 when compared to their metastatic derivatives to the bone (MDA-MB-231BO) and brain (MDA-MB-231BR). This evidence concerns the gene KDR and Hyperglycemia.